ADAPTABLE: Low-dose aspirin as good as high-dose in CHD?May 15, 2021Acute Coronary SyndromesCAD & AtherosclerosisPreventive CareStrokeLipid DisordersThrombosis
PARADISE-MI: Sacubitril/valsartan can’t beat ramipril in patients with acute MIMay 15, 2021Heart FailureAcute Coronary SyndromesCAD & AtherosclerosisLipid Disorders
ACC 21 looks to repeat success despite pandemic headwindsMay 13, 2021CAD & AtherosclerosisAcute Coronary SyndromesArrhythmias & EPHeart FailureHypertensionInterventional Cardiology & SurgeryLipid Disorders
A ‘mess’ of a diagnosis: Is it type 2 MI or a nonischemic imposter?May 11, 2021Acute Coronary SyndromesCAD & AtherosclerosisArrhythmias & EP
Finerenone scores second pivotal-trial success in patients with diabetic kidney diseaseMay 10, 2021DiabetesAcute Coronary SyndromesCAD & Atherosclerosis
Higher MI shock survival with NCSI protocol: Final resultsApril 30, 2021Acute Coronary SyndromesHeart Failure
COVID plus MI confers poor prognosis; 1 in 3 die in hospitalApril 22, 2021Acute Coronary SyndromesCAD & AtherosclerosisCOVID-19 UpdatesInterventional Cardiology & Surgery
PTSD linked to ischemic heart diseaseApril 21, 2021CAD & AtherosclerosisInterventional Cardiology & SurgeryAcute Coronary SyndromesMixed Topics
Cardiovascular disease remains leading cause of type 2 diabetes mortalityApril 6, 2021Acute Coronary SyndromesCAD & AtherosclerosisDiabetes
Six pregnancy complications flag later heart disease riskApril 2, 2021StrokeAcute Coronary SyndromesDiabetesHypertensionLipid DisordersPreventive CareDiabetes
Febuxostat, allopurinol real-world cardiovascular risk appears equalMarch 30, 2021Acute Coronary Syndromes
Arcalyst gets FDA nod as first therapy for recurrent pericarditisMarch 26, 2021Acute Coronary SyndromesMixed Topics
ApoB may better predict mortality risk in statin-treated patientsMarch 24, 2021CAD & AtherosclerosisLipid DisordersAcute Coronary Syndromes
